Do you want to read an article? Please log in or register.
Blood biomarkers to predict short-term pulmonary exacerbation risk in children and adolescents with CF: A pilot study
Pulmonary Fibrosis
Related content
RECOMMENDED
COPD
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study
Respir Res.
Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A
doi: 10.1186/s12931-018-0951-4.
RECOMMENDED
Further Publications
Exhaled volatile organic compounds detect pulmonary exacerbations early in children with cystic fibrosis: results of a 1 year observational pilot study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Breath Res
van Horck M, Smolinska A, Wesseling G, de Winter-de Groot K, de Vreede I, Winkens B, Jöbsis Q, Dallinga J, Dompeling E, van Schooten FJ
doi: 10.1088/1752-7163/abda55
Asthma
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
Lancet Respir Med.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zheng J, Gustafson P, Lamarca R, Puu M, Keen C, Alagappan VKT, Reddel HK
doi: 10.1016/S2213-2600(20)30416-1.
RECOMMENDED
Pulmonary Fibrosis
BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Ishak A, Stick SM, Turkovic L, Ranganathan SC, King L, Harrison J, Sly PD, Caudri D, Schultz A, AREST CF.
doi: 10.1016/j.chest.2020.06.044.
RECOMMENDED
COPD
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Singh D, Wedzicha JA, Siddiqui S, de la Hoz A, Xue W, Magnussen H, Miravitlles M, Chalmers JD, Calverley PMA
doi: 10.1186/s12931-020-01482-1.
AsthmaCOPD
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
Lancet Respir Med.
Bafadhel M, Peterson S, De Blas MA, Calverley PM, Rennard SI, Richter K, Fagerås M
doi: 10.1016/
RECOMMENDED
COPD
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in Chronic Obstructive Pulmonary Disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Esther CR Jr, O'Neal WK, Anderson WH, Kesimer M, Ceppe A, Doerschuk CM, Alexis NE, Hastie AT, Barr RG, Bowler RP, Wells JM, Oelsner EC, Comellas AP, Tesfaigzi Y, Kim V, Paulin LM, Cooper CB, Han MK, Huang YJ, Labaki WW, Curtis JL, Boucher RC, SPIROMICS.
doi: 10.1016/j.chest.2021.10.049
Pulmonary Fibrosis
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Lancet Respir Med.
Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N
doi: 10.1016/
RECOMMENDED
Pulmonary Fibrosis
Effects of a long-term exercise program on motor performance in children and adolescents with CF
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Pediatr Pulmonol.
Gruber W, Stehling F, Olivier M, Benzrath S, Koerner-Rettberg C, Sutharsan S, Taube C, Mellies U, Welsner M
doi: 10.1002/ppul.25064.